Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer

Lung Cancer

Volumn 63, Issue 1, 2009, Pages 106-110

  Lee, Jin Gu ^a   Cho, Byoung Chul ^a   Bae, Mi Kyung ^a   Lee, Chang Young ^a   Park, In Kyu ^a   Kim, Dae Joon ^a   Ahn, Song Vogue ^a   Chung, Kyung Young ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

C reactive protein; Lymphovascular invasion; Non small cell lung cancer; Tumor size

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATELECTASIS; CANCER INVASION; CANCER SIZE; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; LYMPHOVASCULAR INVASION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE LINEAR REGRESSION ANALYSIS; PLEURA METASTASIS; PNEUMONIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SMOKING; SQUAMOUS CELL CARCINOMA; STUDENT T TEST; TISSUE SECTION; TUMOR NECROSIS;

ADULT; AGED; C-REACTIVE PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 57649101361     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.04.011     Document Type: Article

References (28)

1. Black S., Kushner I., and Samols D. C-reactive protein. J Biol Chem 279 47 (2004) 48487-48490
2. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 389 (1982) 39-48
3. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
4. Nozoe T., Matsumato T., Kitamura M., and Sugimachi K. Significance of preoperative elevation of serum c-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 176 (1998) 335-338
5. Nielsen H.J., Christensen I.J., Sørensen S., Moesgaard F., and Brünner N. Preoperative plasma plasminogen activator inhibitor type-1 and serum c-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 7 (2000) 617-623
6. Gockel I., Dirksen K., Messow C.M., and Junginger T. Significance of preoperative c-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol 12 (2006) 3746-3750
7. Nozoe T., Saeki H., and Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 182 2 (2001) 197-201
8. Hashimoto K., Ikeda Y., Korenaga D., Tanoue K., Hamatake M., Kawasaki K., et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103 (2005) 1856-1864
9. Miyata Y., Koga S., Nishikido M., Noguchi M., Kanda S., Hayashi T., et al. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology 58 (2001) 161-164
10. Lamb G.W., McMillan D.C., Ramsey S., and Aitchison M. The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer 94 (2006) 781-784
11. Scott H.R., McMillan D.C., Forrest L.M., Brown D.J., McArdle C.S., and Milroy R. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87 3 (2002) 264-267
12. Jones J.M., McGinogle N.C., McAnespie M., Cran G.W., and Graham A.N. Plasma fibrinogen and serum c-reactive protein are associated with non-small cell lung cancer. Lung Cancer 53 (2006) 97-101
13. Hara M., Matsuzaki Y., Shimuzu T., Tomita M., Ayabe T., Enomoto Y., et al. Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 27 (2007) 3001-3004
14. Mountain C.F. Revision of the international system for staging lung cancer. Chest 111 (1997) 1710-1717
15. Uhlenbruck G., Sölter J., and Janssen E. New reaction mechanisms of C-reactive protein (CRP) and related proteins. J Clin Chem Clin Biochem 19 12 (1981) 1201-1208
16. Helzlsouer K.J., Erlinger T.P., and Platz E.A. C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 42 (2006) 704-707
17. Elliott R.L., and Blobe G.C. Role of transforming growth factor Beta in human cancer. J Clin Oncol 23 (2005) 2078-2093
18. Mangi M.H., and Newland A.C. Interleukin-3 in hematology and oncology: current state of knowledge and future directions. Cytokines Cell Mol Ther 5 (1999) 87-95
19. Saito K., Kawakami S., Ohtsuka Y., Fujii Y., Masuda H., Kumagai J., et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int 100 2 (2007) 269-273
20. Fujisawa T., Yamaguchi Y., Saitoh Y., Hiroshima K., and Ohwada H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected non-small cell carcinoma of the lung with intrapulmonary metastases. Cancer 76 (1995) 2464-2470
21. Rigau V., Molina T.J., Chaffaud C., Huchon G., Audouin J., Chevret S., et al. Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung Cancer 38 (2002) 169-176
22. Ichinose Y., Yano T., Asoh H., Yokoyama H., Yoshino I., and Katsuda Y. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer. An analysis in each pathologic stage. J Thorac Cardiovasc Surg 110 (1995) 601-605
23. Suzuki K., Nagai K., Yoshida J., Nishimura M., Takahashi K., Yokose T., et al. Conventional clinicopathologic prognostic factors in surgically resected non-small cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer 86 (1999) 1976-1984
24. Roberts T.E., Hasleton P.S., Musgrove C., Swindell R., and Lawson R.A. Vascular invasion in non-small cell lung carcinoma. J Clin Pathol 45 (1992) 591-593
25. Tsuchiya T., Hashizume S., Akamine S., Muraoka M., Honda S., Tsuji K., et al. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer. Chest 132 1 (2007) 170-177
26. Kessler R., Gasser B., Massard G., Roeslin N., Meyer P., Wihlm J., et al. Blood vessel invasion is a major prognostic factor in resected non small cell lung cancer. Ann Thorac Surg 62 (1996) 1489-1493
27. Fontanini G., Bigini D., Vignati S., Basolo F., Mussi A., Lucchi A., et al. Microvessel count predicts metastatic disease and survival in non small cell lung cancer. J Pathol 177 1 (1995) 57-63
28. Cote R.J. Occult metastases: real harm or false alarm?. J Thorac Cardiovasc Surg 126 2 (2003) 10-15